Stroke:卒中患者1年后每日能走多远,跟哪些因素有关?

2021-03-11 MedSci原创 MedSci原创

卒中后2个月时的每日步数和平衡性是预测患者未来每日步数的最强指标。改善日常体力活动和平衡性可能是增加卒中患者1年时后体力活动的必要条件。

步行可提高卒中后患者耐力和社区参与度。每日步数超过6000步可降低卒中风险。早期识别那些每日步数较少的个体,可以促进精准干预,从而增加其步数和改善其健康。

近日,血管疾病领域权威杂志Stroke上发表了一篇研究文章,该研究旨在:(1)明确在卒中后2个月时哪些因素可以预测患者1年后的每日步数,(2)明确在卒中后2个月时多少步数可对应于预测卒中后1年时患者每日步数可超过6000步。

这是对卒中后运动体验应用试验数据的二次分析,该试验招募了卒中后2个月步行速度<0.80米/秒的受试者。研究人员分别在受试者卒中后2个月和1年评估了每日步数。基于年龄、性别、种族和/或民族、卒中严重程度、步行速度、耐力、健康状况、运动功能、平衡和平衡信心等因素,研究人员使用线性回归预测了受试者1年时的每日步数。受试者工作特性曲线决确定了在一年内可达到6000步以上受试者在卒中后2月时对应的每日步数。

研究人员分析了206名受试者的数据,平均年龄为63(13)岁,43%为女性,平均每日基线步数为2922(2749)步。预测卒中后1年每日步数的最终模型包括卒中后2个月时的每日步数和平衡性(Berg平衡量表评分);这些因素解释了卒中后1年时每日步数变异性的38%(P≤0.001)。在卒中后2个月时每日步数≥1632步的受试者在卒中后1年时达到每日步数6000以上的可能性增加1.86倍(95%CI为1.52-2.27)。

由此可见,卒中后2个月时的每日步数和平衡性是预测患者未来每日步数的最强指标。改善日常体力活动和平衡性可能是增加卒中患者1年时后体力活动的必要条件

原始出处:

Reed Handlery.et al.Predictors of Daily Steps at 1-Year Poststroke A Secondary Analysis of a Randomized Controlled Trial.stroke.2021.https://www.ahajournals.org/doi/10.1161/STROKEAHA.121.034249

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1720372, encodeId=2abb1e2037274, content=<a href='/topic/show?id=915c3604e6b' target=_blank style='color:#2F92EE;'>#卒中患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36047, encryptionId=915c3604e6b, topicName=卒中患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=940232842333, createdName=wangyang7969, createdTime=Tue Feb 15 12:39:48 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978054, encodeId=c10b9e805488, content=很有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ee45099722, createdName=鑫**, createdTime=Tue Jun 29 23:20:52 CST 2021, time=2021-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1026793, encodeId=43e91026e93bd, content=卒中虽然是临床上常见病,溶栓,取栓等血管内治疗也很成熟,但是仍然有很多未知问题有待认知!, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=健健, createdTime=Fri Mar 12 02:39:48 CST 2021, time=2021-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947558, encodeId=165c94e558ca, content=不错,有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJcGJqKUPQfzFe7a8feqiaEddI4Gduh7XBe6VU0sFHqDjd4eyYsUibbHAjn43EKbHQOaicWnzEm3IdAw/132, createdBy=08e25169489, createdName=ms7740660289060939, createdTime=Fri Mar 12 01:12:00 CST 2021, time=2021-03-12, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1720372, encodeId=2abb1e2037274, content=<a href='/topic/show?id=915c3604e6b' target=_blank style='color:#2F92EE;'>#卒中患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36047, encryptionId=915c3604e6b, topicName=卒中患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=940232842333, createdName=wangyang7969, createdTime=Tue Feb 15 12:39:48 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978054, encodeId=c10b9e805488, content=很有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ee45099722, createdName=鑫**, createdTime=Tue Jun 29 23:20:52 CST 2021, time=2021-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1026793, encodeId=43e91026e93bd, content=卒中虽然是临床上常见病,溶栓,取栓等血管内治疗也很成熟,但是仍然有很多未知问题有待认知!, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=健健, createdTime=Fri Mar 12 02:39:48 CST 2021, time=2021-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947558, encodeId=165c94e558ca, content=不错,有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJcGJqKUPQfzFe7a8feqiaEddI4Gduh7XBe6VU0sFHqDjd4eyYsUibbHAjn43EKbHQOaicWnzEm3IdAw/132, createdBy=08e25169489, createdName=ms7740660289060939, createdTime=Fri Mar 12 01:12:00 CST 2021, time=2021-03-12, status=1, ipAttribution=)]
    2021-06-29 鑫**

    很有用

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1720372, encodeId=2abb1e2037274, content=<a href='/topic/show?id=915c3604e6b' target=_blank style='color:#2F92EE;'>#卒中患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36047, encryptionId=915c3604e6b, topicName=卒中患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=940232842333, createdName=wangyang7969, createdTime=Tue Feb 15 12:39:48 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978054, encodeId=c10b9e805488, content=很有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ee45099722, createdName=鑫**, createdTime=Tue Jun 29 23:20:52 CST 2021, time=2021-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1026793, encodeId=43e91026e93bd, content=卒中虽然是临床上常见病,溶栓,取栓等血管内治疗也很成熟,但是仍然有很多未知问题有待认知!, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=健健, createdTime=Fri Mar 12 02:39:48 CST 2021, time=2021-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947558, encodeId=165c94e558ca, content=不错,有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJcGJqKUPQfzFe7a8feqiaEddI4Gduh7XBe6VU0sFHqDjd4eyYsUibbHAjn43EKbHQOaicWnzEm3IdAw/132, createdBy=08e25169489, createdName=ms7740660289060939, createdTime=Fri Mar 12 01:12:00 CST 2021, time=2021-03-12, status=1, ipAttribution=)]
    2021-03-12 健健

    卒中虽然是临床上常见病,溶栓,取栓等血管内治疗也很成熟,但是仍然有很多未知问题有待认知!

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1720372, encodeId=2abb1e2037274, content=<a href='/topic/show?id=915c3604e6b' target=_blank style='color:#2F92EE;'>#卒中患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36047, encryptionId=915c3604e6b, topicName=卒中患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=940232842333, createdName=wangyang7969, createdTime=Tue Feb 15 12:39:48 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978054, encodeId=c10b9e805488, content=很有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ee45099722, createdName=鑫**, createdTime=Tue Jun 29 23:20:52 CST 2021, time=2021-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1026793, encodeId=43e91026e93bd, content=卒中虽然是临床上常见病,溶栓,取栓等血管内治疗也很成熟,但是仍然有很多未知问题有待认知!, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=健健, createdTime=Fri Mar 12 02:39:48 CST 2021, time=2021-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947558, encodeId=165c94e558ca, content=不错,有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJcGJqKUPQfzFe7a8feqiaEddI4Gduh7XBe6VU0sFHqDjd4eyYsUibbHAjn43EKbHQOaicWnzEm3IdAw/132, createdBy=08e25169489, createdName=ms7740660289060939, createdTime=Fri Mar 12 01:12:00 CST 2021, time=2021-03-12, status=1, ipAttribution=)]
    2021-03-12 ms7740660289060939

    不错,有用

    0

相关资讯

Lancet Neurology:无症状颈动脉狭窄程度与卒中风险的关系:一项基于人群的队列研究、系统回顾和荟萃分析

两项大型的随机对照试验证明,颈动脉内膜切除术对于近期有症状的颈动脉狭窄患者预防卒中的益处,其所观察到的益处在很大程度上取决于狭窄程度。

Neurology:超20万人群研究证实,多吃素可将卒中风险降低10%

俗话说的好,民以食为天。“吃”一件重要的事,也是是一件快乐的事,健康合理均衡的饮食不仅能保持机体的健康,也能带来很多快乐。

Stroke:卒中后长期服用普拉格雷或氯吡格雷治疗的血压和变异性水平

较高的平均SBP水平和随访变异性与普拉格雷或氯吡格雷长期治疗期间卒中复发的风险显着相关。无论使用哪种抗血小板药物,控制高血压都尤为重要。

Lancet:牛津大学研究发现“非典型小卒中”的危害大到你想不到

与典型TIA发作相比,非典型TIA发作患者具有较高的早期和长期中风风险。将症状不典型的患者考虑入内后,TIA诊断将增加约50%。

Stroke:采用非维生素K拮抗剂口服抗凝药预防卒中的房颤患者脑出血危险因素分析

一些危险因素与服用NOAC预防卒中的患者ICH发生相关,但HAS-BLED和CHA2DS2-VASc得分与其无关。

JACC:1.4万人双盲随机试验| 不同剂量的依度沙班预防房颤患者卒中的净临床结局

在ENGAGE AF-TIMI 48试验中,低剂量依度沙班(edoxaban)方案(LDER)和高剂量依度沙班方案(HDER)在预防心房颤动卒中的效果不逊于管理良好的华法林。